OTC Markets OTCQX - Delayed Quote USD

Interpace Biosciences, Inc. (IDXG)

1.0000
0.0000
(0.00%)
At close: April 24 at 12:25:09 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
46,926
46,926
40,036
31,838
33,117
Cost of Revenue
17,001
17,001
14,980
13,607
14,314
Gross Profit
29,925
29,925
25,056
18,231
18,803
Operating Expense
21,817
21,817
21,093
22,071
24,567
Operating Income
8,108
8,108
3,963
-3,840
-5,764
Net Non Operating Interest Income Expense
-659
-659
-1,008
-1,008
-1,040
Other Income Expense
-499
-499
-674
-988
-938
Pretax Income
6,950
6,950
2,281
-5,836
-7,742
Tax Provision
4
4
17
29
-705
Net Income Common Stockholders
6,238
6,238
1,954
-21,958
-14,943
Diluted NI Available to Com Stockholders
6,238
6,238
1,954
-21,958
-14,943
Basic EPS
1.42
1.42
0.45
-5.18
-3.61
Diluted EPS
0.40
0.40
0.45
-5.18
-3.61
Basic Average Shares
4,387
4,387
4,317
4,238
4,135
Diluted Average Shares
15,734
15,734
4,364
4,238
4,135
Total Operating Income as Reported
8,108
8,108
3,956
-3,617
-6,336
Total Expenses
38,818
38,818
36,073
35,678
38,881
Net Income from Continuing & Discontinued Operation
6,702
6,702
1,954
-21,958
-14,943
Normalized Income
6,946
6,946
2,270.9478
-6,041.1700
-6,528.8690
Interest Expense
659
659
1,008
1,008
1,040
Net Interest Income
-659
-659
-1,008
-1,008
-1,040
EBIT
7,609
7,609
3,289
-4,828
-6,702
EBITDA
8,357
8,357
4,890
-1,326
-1,328
Reconciled Cost of Revenue
16,253
16,253
14,240
11,375
12,132
Reconciled Depreciation
748
748
1,601
3,502
5,374
Net Income from Continuing Operation Net Minority Interest
6,946
6,946
2,264
-5,865
-7,037
Total Unusual Items Excluding Goodwill
--
--
-7
223
-559
Total Unusual Items
--
--
-7
223
-559
Normalized EBITDA
8,357
8,357
4,897
-1,549
-769
Tax Rate for Calcs
0
0
0
0.0002
0.0001
Tax Effect of Unusual Items
--
--
-0.0522
46.8300
-50.8690
12/31/2021 - 7/9/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RNVA Rennova Health, Inc.
0.0001
0.00%
 
BDSX Biodesix, Inc.
0.5712
+15.35%
 
PEB.NZ Pacific Edge Limited
0.1140
-7.32%
 
AVCR.V Avricore Health Inc.
0.0550
+22.22%
 
AWHL Aspira Women's Health Inc.
0.0396
+49.43%
 
CSTL Castle Biosciences, Inc.
20.93
-1.60%
 
VCYT Veracyte, Inc.
32.14
+2.15%
 
PRPO Precipio, Inc.
6.73
-12.60%
 
LH Labcorp Holdings Inc.
228.58
+1.98%
 
DGX Quest Diagnostics Incorporated
175.87
+1.33%